Literature DB >> 19015915

To measure the unmeasurable.

Michael Gnant1.   

Abstract

Mesh：

Substances：

Year:  2009        PMID： 19015915     DOI： 10.1007/s00268-008-9801-8

Source DB:  PubMed          Journal:  World J Surg        ISSN： 0364-2313            Impact factor:   3.352


× No keyword cloud information.
  9 in total

Review 1.  Neoadjuvant chemotherapy for operable breast cancer.

Authors:  J S D Mieog; J A van der Hage; C J H van de Velde
Journal:  Br J Surg       Date:  2007-10       Impact factor: 6.939

2.  Prognostic imaging in neoadjuvant chemotherapy of locally-advanced breast cancer should be cost-effective.

Authors:  Marc Schegerin; Anna N A Tosteson; Peter A Kaufman; Keith D Paulsen; Brian W Pogue
Journal:  Breast Cancer Res Treat       Date:  2008-04-25       Impact factor: 4.872

3.  Can early response assessment guide neoadjuvant chemotherapy in early-stage breast cancer?

Authors:  Francisco J Esteva; Gabriel N Hortobagyi
Journal:  J Natl Cancer Inst       Date:  2008-04-08       Impact factor: 13.506

4.  Invasive ductal carcinoma and invasive lobular carcinoma of breast differ in response following neoadjuvant therapy with epidoxorubicin and docetaxel + G-CSF.

Authors:  Catharina Wenzel; Rupert Bartsch; Dagmar Hussian; Ursula Pluschnig; Gabriela Altorjai; Christoph C Zielinski; Alois Lang; Anton Haid; Raimund Jakesz; Michael Gnant; Guenther G Steger
Journal:  Breast Cancer Res Treat       Date:  2006-10-24       Impact factor: 4.872

5.  Clinicopathological features of tumors as predictors of the efficacy of primary neoadjuvant chemotherapy for operable breast cancer.

Authors:  Tadahiko Shien; Sadako Akashi-Tanaka; Kunihisa Miyakawa; Takashi Hojo; Chikako Shimizu; Kunihiko Seki; Masashi Ando; Tsutomu Kohno; Naruto Taira; Hiroyoshi Doihara; Noriyuki Katsumata; Yasuhiro Fujiwara; Takayuki Kinoshita
Journal:  World J Surg       Date:  2009-01       Impact factor: 3.352

Review 6.  Imaging techniques to evaluate the response to treatment in oncology: current standards and perspectives.

Authors:  C D Marcus; V Ladam-Marcus; C Cucu; O Bouché; L Lucas; C Hoeffel
Journal:  Crit Rev Oncol Hematol       Date:  2008-08-29       Impact factor: 6.312

7.  Molecular classification system identifies invasive breast carcinoma patients who are most likely and those who are least likely to achieve a complete pathologic response after neoadjuvant chemotherapy.

Authors:  Neal S Goldstein; David Decker; Dawn Severson; Scott Schell; Frank Vicini; Jeffrey Margolis; Nayana S Dekhne
Journal:  Cancer       Date:  2007-10-15       Impact factor: 6.860

Review 8.  Preoperative chemotherapy treatment of breast cancer--a review.

Authors:  Aman U Buzdar
Journal:  Cancer       Date:  2007-12-01       Impact factor: 6.860

9.  Surgical margins in breast-conservation operations for invasive carcinoma: does neoadjuvant chemotherapy have an impact?

Authors:  Geneviève Soucy; Julie Bélanger; Guy Leblanc; Lucas Sideris; Pierre Drolet; Andrew Mitchell; Yves E Leclerc; Michel P Dufresne; Julie Beaudet; Pierre Dubé
Journal:  J Am Coll Surg       Date:  2008-03-03       Impact factor: 6.113
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.